This observation is consistent with recent findings showing that the exposure of patient-derived dedifferentiated liposarcoma cell lines to QN-302 leads to substantial p53 accumulation, due to the compound’s ability to directly interfere with MDM2 expression [34]. This evidence concerns the gene TP53 and liposarcoma.